Stock Information
MapLight Therapeutics Inc (MPLT)
Ticker Symbol: MPLT
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,365.27 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -2.5995
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: N/A%
Latest News
-
HC Wainwright & Co. Reiterates Buy on MapLight Therapeutics, Maintains $45 Price Target
Thu, May 28, 2026 8:24 AM
-
UBS Initiates Coverage On MapLight Therapeutics with Buy Rating, Announces Price Target of $48
Wed, May 27, 2026 2:08 PM
Key Financials
Financial data not available